AACR 2021 roundup
Evaluate Vantage's coverage of the virtual AACR 2021 congress.
In advance of AACR, Evaluate Vantage's Jacob Plieth spoke to the biotech investor Brad Loncar about the meeting's themes.
Also check out our coverage of AACR 2021.
April 12
AACR 2021 – Pieris might have to bet on combinations
April 10
AACR 2021 – still awaiting validation, Sanofi keeps on buying
The group does not let the grass grow under its feet, acquiring Tidal Therapeutics before its bigger Synthorx buy has proven itself.
AACR 2021 – Affimed wins, Oncternal loses
Phase 1 results at this weekend’s virtual AACR show an unexpected win for Affimed’s AFM13 and a disappointing update from Oncternal.
March 26
Boehringer’s big cancer reveal draws near
The company might finally become an oncology player.
March 22
AACR 2021 preview – the early themes emerge
The most important of this year’s two virtual AACRs features immunotherapy combos, new Kras players and first clinical data for several assets.
Related Topics
Share This Article
